France incompetent, or just dependent?

    France incompetent, or just dependent?

    With a campaign slower at the start than its neighbors, doubts about French strategy have multiplied; and if there is a form of “unhappy consciousness”, the forced introspection that economists and other researchers put on it is no less painful.

    Two accused: the health administration with 4 or 5 organizations working in parallel, points in The echoes Pascal Perri: “failure” of a “controlling administration” he says, excess of centralism and outsourcing skills write in Economic Alternatives three sociologists, authors of a book on the “organizational crisis” of Covid-19. This is the renewed and tragic theme of the organizing State of its incompetence and its weak competitiveness in the vaccine race.

    With her on the bench: a very – or too – political “prudence”, with decisions more “appeasing” than “relevant”, always laments in The echoes engineer Victor Storchan, even downright “demagogic” coward Pascal Perri. The Government, which is now accelerating, may plead “not to confuse speed and haste” and have welcomed the threshold of 100,000 vaccinations reached on Sunday, “the cruising speed” has not yet been reached and for Pascal Perri he condemns himself as crazy Einstein to “always do the same thing hoping for a different result!”.

    Hazardous management?

    Some episodes crystallized the suspicions: first the use of 4 consulting firms, including McKinsey which would have touched € 100 million, specifies Release : simple effect of a “contemporary managerial fashion” promoting small groups and “agile” decisions as our three sociologists regret? or true “cultural conversion, if not economic […] to the culture of remote abstract management “which would have become the” trademark of macronism “? says Luc Rouban from Cevipof.

    Be that as it may, this “outsourcing of expertise” reinforces mistrust, even if the government invokes its need for support to carry out major projects: the result of a series of denials, diagnoses the young economist at MIT Antoine Levy in the Figaro Vox, indignant that France is the only member of the UN Security Council not to have developed its own vaccine – since Sanofi only plans to do so at the end of the year – and that the crisis reveals its “Administrative, technical, industrial, scientific incompetence…” In short, more than introspection, it would be psychosis: “the unconscious in the open”.

    Parsimonious logistics?

    It is “meticulous management”, assures the Straté site: from the Pfizer / BioNTech plant in Puurs in Belgium to the 6 platforms, then to the hundred or so health establishments, but also nursing homes and hospitals, everything by maintaining a cold chain ranging from isothermal packages with “dry ice” and integrated GPS, to super-freezers in France: it is the most expensive sorbet in the world, logistics represent up to 80% of costs according to Imperial College London.

    The government’s strategy is however riddled with suspicion, between the rumors from Matignon on a loss of doses and the doubts about the actually available number of the 113 super-freezers for the Pfizer / BioNTech vaccine or that of doses ordered and delivered: the 50 000 first Moderna vaccines, 2nd validated on Friday, only arrive this week.

    Unpreparedness and “chaotic beginnings”, deplores in The JDD, the environmentalist deputy and former professional François Michel Lambert, admirer of the campaigns in Germany and Israel – true spartan of logistics with “0 stock”, where the “culture of scarcity” leads to “performance”, while on the contrary – we were talking about it here – France is in the process of logistical downgrading; however tempers The echoes, with the 3rd Astrazeneca vaccine, Paris should avoid the risk of shortage: it is the resistible rise in the shortage.

    Difficulties for new orders?

    Paris does not decide alone since these doses are collectively pre-purchased at 6 laboratories by the European Commission and the States order according to quotas proportional to their population, 15% for France: this “basket” of secure vaccines allows the ‘EU to obtain a better wholesale price explains Dominique Seux of Echos, but it can also jam it with orders of vaccines not yet ready or validated, such as that of Sanofi or the American Curevac.

    Furthermore, the supply is not guaranteed: the most effective Pfizer / BioNtech and Moderna, including against the English variant, are the most in demand worldwide; and some EU states might want to go it alone: ​​part of the German press suspected France of having favored Sanofi when Berlin itself is accused of having made its own agreements with two laboratories for a few tens of millions of additional doses. The Commission denied any favoritism but also called for an end to “side contracts”.

    Incompetence or dependence?

    The Elysee, which called on Friday to strengthen coordination for “vaccine orders and production sites in Europe” is not isolated: the European Commission has just strengthened its program to purchase Pfizer / BioNTech vaccines to rise to 600 million doses and the company will build a second plant in Germany.

    In addition, the government can further intensify the vaccination campaign by extending the target audiences as in Nancy from tomorrow, or even by imposing it, recommends Antoine Levy, even if it means cutting social benefits to those who refuse it if a quota of X% number of vaccinated people is not reached on a given date … Do you shiver? Take Victor Storchan’s call to the Enlightenment to rehabilitate expertise and objectivity, in the spirit of the first “vaccines” against smallpox in 1774: a happy time when “the statistical average triumphed over the legal norm, and the State, enlightened by science, adopted a targeted strategy ”. Encouraging clinical sign: Louis XVI had benefited from it.


    Share Button